Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 461

1.

Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.

Cancer Res. 2006 Mar 1;66(5):2544-52.

2.

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.

Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R.

Oncogene. 2000 Nov 16;19(48):5419-27.

3.

Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.

Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S.

J Cell Physiol. 2009 Mar;218(3):490-500. doi: 10.1002/jcp.21622.

PMID:
18988190
4.

Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.

Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R.

Mol Cancer Res. 2007 Aug;5(8):823-32.

5.
6.

CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.

Won C, Lee CS, Lee JK, Kim TJ, Lee KH, Yang YM, Kim YN, Ye SK, Chung MH.

Anticancer Res. 2010 Feb;30(2):481-8.

PMID:
20332458
7.
8.

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.

Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Clin Cancer Res. 2005 Sep 1;11(17):6333-41.

9.
10.

Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.

Kröger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H.

Cancer Res. 2007 Apr 1;67(7):2972-81.

11.

Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.

Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.

J Natl Cancer Inst. 2006 Sep 6;98(17):1238-47.

PMID:
16954476
12.
13.

[Effects of acitretin on the expression of signaling pathway-related genes in epidermal squamous-cell carcinoma cells].

Cai SQ, Chen LR, Zheng M.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):21-4. Chinese.

PMID:
16737614
14.
17.

ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.

Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, Rabbani SA, Datar R, Cote R, Pestell R, Albanese C.

Cancer Res. 2007 May 1;67(9):4364-72.

18.
19.

Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.

Prostate. 2008 Feb 15;68(3):269-80. doi: 10.1002/pros.20699.

PMID:
18163422

Supplemental Content

Support Center